Impact of metformin versus repaglinide on postprandial glycaemia and plasma lipoproteins in non-obese patients with type-2 diabetes mellitus (T2DM)

被引：0
|
作者：
Lund, S. S. [1 ]
Tarnow, L. [1 ]
Smidt, U. M. [1 ]
Frandsen, M. [1 ]
Pedersen, O. [1 ]
Parving, H-H. [1 ]
Vaag, A. A. [1 ]
机构：
[1] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2007年 / 8卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(07)71734-8
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：193 / 193
页数：1
相关论文
共 50 条
  • [41] Microvascular complications in type 2 diabetes mellitus (T2DM).
    Cheung, AT
    Ramanujam, S
    Duong, PL
    Schauer, D
    Chan, LS
    Dwyre, DM
    Larkin, EC
    FASEB JOURNAL, 2002, 16 (04): : A208 - A208
  • [42] Rapid effect of repaglinide in combination with metformin in poorly controlled obese patients with type 2 diabetes mellitus
    Kurashvili, R.
    Asatiani, N.
    Nishnianidze, M.
    Dundua, M.
    Shelestova, E.
    INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 : S163 - S163
  • [43] The potential effect of metformin on fibroblast growth factor 21 in type 2 diabetes mellitus (T2DM)
    Hayder M. Al-kuraishy
    Ali I. Al-Gareeb
    Hebatallah M. Saad
    Gaber El-Saber Batiha
    Inflammopharmacology, 2023, 31 : 1751 - 1760
  • [44] The potential effect of metformin on fibroblast growth factor 21 in type 2 diabetes mellitus (T2DM)
    Al-kuraishy, Hayder M.
    Al-Gareeb, Ali I.
    Saad, Hebatallah M.
    Batiha, Gaber El-Saber
    INFLAMMOPHARMACOLOGY, 2023, 31 (04) : 1751 - 1760
  • [45] Type 2 diabetes mellitus (T2DM): Clinical and biochemical characteristics of normal weight versus overweight patients
    Farcasiu, E
    Mota, M
    Morosanu, M
    Guja, C
    Ionescu-Tirgoviste, C
    DIABETES, 2002, 51 : A225 - A225
  • [46] Early postprandial glucagon surge affects postprandial glucose levels in obese and non-obese patients with type 2 diabetes
    Kozawa, Junji
    Okita, Kohei
    Iwahashi, Hiromi
    Yamagata, Kazuya
    Imagawa, Akihisa
    Shimomura, Iichiro
    ENDOCRINE JOURNAL, 2013, 60 (06) : 813 - 818
  • [47] Cause of Hospitalizations in Patients with Type 2 Diabetes Mellitus (T2DM) in the CANVAS Program
    Mahaffey, Kenneth W.
    Ianus, Juliana
    Damaraju, C. V.
    Neal, Bruce
    De Zeeuw, Dick
    Fulcher, Greg
    Pfeifer, Michael
    Matthews, David R.
    DIABETES, 2019, 68
  • [48] Characteristics of Patients with Type 2 Diabetes Mellitus (T2DM) Initiating Therapy with Canagliflozin
    Martin, Silas C.
    Henk, Henry J.
    Chow, Wing
    DIABETES, 2014, 63 : A307 - A307
  • [49] Thioazolidinediones are useful in treating non-obese patients with type 2 diabetes mellitus
    Tanaka, Y
    Kitamura, R
    Seo, M
    Ihara, Y
    Yamamoto, Y
    Ogata, T
    Motoyoshi, K
    DIABETES, 2002, 51 : A134 - A135
  • [50] METABOLIC SURGERY FOR NON-OBESE TYPE 2 DIABETES MELLITUS ASIAN PATIENTS
    Lee, Wei-Jei
    Ser, Kong-Han
    Lee, Ming-Hsien
    Chen, Shu-Chu
    Tsou, Jun-Juin
    Chen, Jung-Chien
    OBESITY SURGERY, 2015, 25 (08) : 1310 - 1310
12345